| abstract |
Use of ivermectin to produce a topical pharmaceutical composition for the treatment of rosacea, whose composition is in the form of an emulsion consisting of: a) an oily phase that includes fatty substances, b) at least one surfactant emulsifier, c) ivermectin, d ) a mixture of solvent (s) and / or propenetrating agent (s) for the active substance, which are selected from propylene glycol, ethanol, isopropanol, butanol, N-methyl-2-pyrrolidone or DMSO, polysorbate 80 and phenoxyethanol, and containing propylene glycol, e) and water. |